Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Brain Res ; 1268: 135-141, 2009 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-19269279

RESUMEN

The clinical picture of viral encephalitis is determined by the affinity and persistence of the virus to different brain regions. Therefore, the present study was aimed to investigate the neuropathological changes following Japanese encephalitis virus (JEV) infection in rat at different time points. Twelve days old Wistar rats were infected by intracerebral inoculation of JEV. Presence of JEV antigen was detected in thalamus, striatum, cortex and mid brain on 3, 6, 10 and 20 days post inoculation (d.p.i.). Histopathological changes were also studied in different brain regions at different time points. The highest expression of JEV antigen was found on 6 dpi in all the brain regions studied. JEV antigen was maximum in thalamus on 6 d.p.i. and mid brain on 10 d.p.i. JEV antigen, however, was almost undetectable on 20 d.p.i. in all the regions. The classical pathological changes such as cellular infiltration, perivascular cuffing, meningeal disruption, neuronal damage, neuronal shrinkage, and plaque formation were observed up to 10 d.p.i. The present study reveals high affinity of JEV to thalamus, brainstem and striatum. Rat model of JEV infection may serve as a useful model for studying mechanism of cell injury and recovery in JE.


Asunto(s)
Encéfalo/patología , Encéfalo/virología , Virus de la Encefalitis Japonesa (Especie)/aislamiento & purificación , Encefalitis Japonesa/patología , Encefalitis Japonesa/virología , Análisis de Varianza , Animales , Animales Lactantes , Corteza Cerebral/patología , Corteza Cerebral/virología , Cuerpo Estriado/patología , Cuerpo Estriado/virología , Femenino , Inmunohistoquímica , Masculino , Mesencéfalo/patología , Mesencéfalo/virología , Neuronas/patología , Neuronas/virología , Ratas , Ratas Wistar , Tálamo/patología , Tálamo/virología
2.
Restor Neurol Neurosci ; 21(1-2): 1-10, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12808197

RESUMEN

PURPOSE: Adeno-associated virus (AAV) can infect a wide variety of mammalian cell types and is capable of infecting both dividing and non-dividing cell populations. Here we report the construction of a recombinant AAV vector which expresses the SV40 large T protein (AAV-T) and the use of this vector to immortalize primary cells from embryonic rat mesencephalon. METHODS: The AAV-T vector was constructed by introducing the BamH1 fragment of the pCMV/SVE/Neo plasmid containing T antigen and SV40 regulatory elements into the JM48 plasmid containing the inverted terminal repeats of AAV. Neuronal cultures from E-12 rat mesencephalon were grown in defined media supplemented with basic fibroblast growth factor. These cells were infected with the AAV-T vector. RESULTS: A cell line (designated RMAT) and six subclones were established from these cultures through multiple passages. This cell line was immunoreactive for SV40 large T antigen and the cytoskeletal proteins nestin and vimentin. Morphological differentiation and expression of neurofilament 160 kDa were induced by exposure to dibutyrl cyclic AMP. Immunoassays performed to measure endogenous production of growth factors showed that RMAT cells produced high levels of platelet-derived growth factor (PDGF). CONCLUSIONS: AAV may be a useful vector for the transduction of oncogenes to produce cell lines.


Asunto(s)
Antígenos Transformadores de Poliomavirus/metabolismo , Transformación Celular Viral/fisiología , Mesencéfalo/citología , Proteínas del Tejido Nervioso , Factor de Crecimiento Derivado de Plaquetas/biosíntesis , Transducción Genética , 1-Metil-3-Isobutilxantina/farmacología , Animales , Antígenos Transformadores de Poliomavirus/química , Antineoplásicos/farmacología , Western Blotting , Bucladesina/farmacología , Diferenciación Celular/efectos de los fármacos , Tamaño de la Célula/efectos de los fármacos , Células Cultivadas/microbiología , Dependovirus/genética , Interacciones Farmacológicas , Embrión de Mamíferos , Ensayo de Inmunoadsorción Enzimática , Femenino , Factores de Crecimiento de Fibroblastos/metabolismo , Regulación Viral de la Expresión Génica , Vectores Genéticos/genética , Inmunohistoquímica , Proteínas de Filamentos Intermediarios/metabolismo , Mesencéfalo/metabolismo , Mesencéfalo/virología , Factores de Crecimiento Nervioso/farmacología , Nestina , Neuronas/citología , Inhibidores de Fosfodiesterasa/farmacología , Embarazo , Ratas , Factores de Tiempo , Tretinoina/farmacología
3.
Mov Disord ; 15(6): 1168-72, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11104201

RESUMEN

Encephalitis has been reported to be a rare cause of severe dystonia. We describe five patients with markedly severe dystonia from Japanese encephalitis. These patients with markedly severe dystonia were seen during the past 8 years as a subgroup of 50 patients with Japanese encephalitis. The diagnosis of markedly severe dystonia was based on increasingly frequent episodes of generalized dystonia with bulbar, respiratory, or metabolic derangement or leading to exhaustion or pain. The diagnosis of JE was based on clinicoradiologic features and a fourfold increase of hemagglutination-inhibiting antibody titers in paired serum. The outcome of the patients was defined as a good, partial, or poor recovery on the basis of 1-year clinical status. All the patients were males, and their ages ranged from 6 to 19 years. Movement disorders appeared 1 to 3 weeks after the illness as the level of consciousness started improving. During the next 1 to 4 weeks, patients began to experience markedly severe dystonia. It was associated with marked axial dystonia resulting in opisthotonus and retrocollis in five patients, jaw-opening dystonia in two patients, teeth clenching in one patient, and oculogyric crisis and neck deviation in another patient. The attacks of markedly severe dystonia lasted for 2 to 30 minutes and occurred as many as 20 to 30 times daily. Other developments included fixed limb dystonia in one patient, severe spasticity and rigidity in five patients, and focal muscle wasting in one patient. These patients had only a modest improvement after treatment. Markedly severe dystonia abated by 2 to 6 months in all the patients who were followed up. Cranial magnetic resonance imaging showed bilateral thalamic involvement in all patients, brainstem involvement in three patients, and basal ganglia involvement in two patients. At the 3-month follow-up, all patients had a poor outcome. At 1 year, one patient had a complete recovery; one had a partial recovery; and two were bedridden. It can be concluded that markedly severe dystonia is an important and serious sequela of Japanese encephalitis and may occur as the result of thalamus, midbrain, or basal ganglia involvement in various combinations.


Asunto(s)
Distonía/virología , Virus de la Encefalitis Japonesa (Especie)/aislamiento & purificación , Encefalitis Japonesa/complicaciones , Tálamo/patología , Adolescente , Adulto , Ganglios Basales/patología , Ganglios Basales/virología , Niño , Progresión de la Enfermedad , Distonía/patología , Encefalitis Japonesa/patología , Humanos , Imagen por Resonancia Magnética , Masculino , Mesencéfalo/patología , Mesencéfalo/virología , Recuperación de la Función , Índice de Severidad de la Enfermedad , Tálamo/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA